DayOne

DayOne stands as Switzerland's premier accelerator for emerging healthtech ventures, specializing in nurturing startups that bridge innovative technology with life sciences. Operating from Basel, the organization leverages its strategic position within Europe's most dynamic life sciences hub to provide comprehensive support for promising early-stage companies. The accelerator's unique approach combines industry expertise, mentorship programs, and access to specialized resources that address the distinct challenges faced by healthtech innovators seeking to disrupt traditional healthcare models.

The accelerator's portfolio reflects a commitment to transformative healthcare solutions across various domains, including digital therapeutics, medical devices, diagnostics, and AI-driven healthcare platforms. By focusing on the intersection of technology and life sciences, DayOne has cultivated a reputation for identifying ventures with significant market potential and scientific validity. Their selection process emphasizes innovations that demonstrate both technical feasibility and the potential to address substantial unmet needs in global healthcare systems, particularly those that can benefit from Switzerland's renowned precision in life sciences.

Portfolio companies benefit from DayOne's extensive ecosystem of industry partnerships, which includes connections to pharmaceutical giants, research institutions, and regulatory experts based in the Basel region. This network provides startups with invaluable opportunities for pilot projects, clinical validation, and strategic collaborations that might otherwise take years to establish independently. The accelerator's mentorship program pairs founders with seasoned entrepreneurs and industry veterans who provide guidance on navigating regulatory pathways, refining business models, and preparing for investment rounds tailored to the unique capital requirements of healthtech ventures.

Beyond initial acceleration, DayOne offers ongoing support through various growth stages, helping portfolio companies secure subsequent funding from specialized investors familiar with the extended development timelines typical in healthtech. The organization has established itself as a trusted gateway for international investors seeking vetted opportunities in European healthtech, while simultaneously connecting Swiss innovations to global markets. This comprehensive approach to venture development has positioned DayOne as a critical catalyst in transforming Switzerland's traditional life sciences excellence into a dynamic healthtech innovation ecosystem with increasing international influence.